Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ ...

The market is characterized by trends such as personalized medicine, targeted therapies, and combination treatments. Key players include Eli Lilly, Bristol Myers Squibb, and AstraZeneca. As North ...

The article continued: The number of annual cancer cases is expected to rise by 20% by 2030 and jump by 75% by 2050, ...

Key points include access to medicines in medicare is reduced as the IRA is implemented; fewer drugs are covered on Medicare ...

Market OverviewThe Global Nanomedicine Market is valued at USD 273.79 Billion in 2024 and is projected to reach a value of ...

A promising approach to achieve safer, more effective, and more precise breast cancer treatment has earned a University of ...

According to Vantage Market Research, the Global Flow Cytometry Market is estimated to be valued at USD 14 Billion by 2035 at ...

The Lupus Research Alliance (LRA) is proud to announce the recipients of this year's Lupus Innovation Award (LIA), addressing many critical themes in lupus research including novel therapeutic ...

The new time-saving test is intended for people with MGUS (Monoclonal Gammopathy of Unknown Significance), a precursor condition of myeloma.

CTLA4 Inhibitors Market forecast to 2035 covers market size, key trends, competitive landscape, and growth opportunities in cancer immunotherapy and autoimmune diseases.